ArticleFrontiers in bioengineering and biotechnology2025

Sequential dual-targeting biomimetic nanovesicles for bone marrow-specific delivery of bortezomib in multiple myeloma.

Chongyan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.